Related Experiment Video
Updated: Jun 27, 2026

09:22
Fabricating Superhydrophobic Polymeric Materials for Biomedical Applications
Published on: August 28, 2015
Diffusion-Controlled Drug Release from Electrospun Poly(3-hydroxybutyrate) Fibers with Beaded Architecture: An
Alexey Iordanskii1, Pavel Borovikov2, Valentina Siracusa3
1Semenov Federal Research Center for Chemical Physics Academy of Science, Kosygina St. 4, 119991 Moscow, Russia.
International Journal of Molecular Sciences
|June 26, 2026
Summary
Electrospinning creates "beads-on-string" bioplastic fibers. These structures enhance drug diffusion and release, enabling tunable performance for sustainable materials like poly(3-hydroxybutyrate).
Area of Science:
- Materials Science
- Nanotechnology
- Biotechnology
Background:
- Electrospinning (ES) is key for sustainable bio-based plastics, producing ultrathin fibers.
- The "beads-on-string" morphology in electrospun fibers, once overlooked, is now recognized for enhanced properties.
- Poly(3-hydroxybutyrate) (PHB) and dipyridamole (DPD) were chosen as model biopolyester and drug, respectively.
Purpose of the Study:
- To explore the valorization of beaded fibers produced by electrospinning.
- To evaluate the impact of beading on drug diffusion and delivery performance.
- To understand how morphological parameters influence release kinetics for pharmaceutical applications.
Main Methods:
- Fabrication of ultrathin PHB fibers with "beads-on-string" morphology using solution electrospinning.
- Characterization of fiber morphology (SEM), thermal properties (DSC), and structure (FTIR).
- Monitoring of drug release kinetics (UV-Vis spectroscopy) and computational modeling of diffusion in fiber domains.
Main Results:
- Morphological parameters of electrospun fibers significantly impact diffusion and release kinetics.
- Computational modeling of drug diffusion aligned well with experimental data.
- "Beads-on-string" architectures offer tunable drug release profiles.
Conclusions:
- The "beads-on-string" morphology in electrospun biopolymers can be exploited for controlled drug delivery.
- This approach allows for the design of materials with tunable absorption, mechanical performance, and release profiles.
- Controlled exploitation of these fibrous architectures supports the development of innovative pharmaceutical platforms using sustainable biopolymers.
